BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7169577)

  • 21. Efficacy of streptococcal preparation OK-432 for gastric cancer patients--comparison between intradermal and intramuscular injection.
    Hanaue H; Kurosawa T; Yoshizaki S; Shikata J
    Jpn J Surg; 1984 May; 14(3):191-7. PubMed ID: 6611437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on enhancement of antitumor immunity in cervical cancer--with reference to administration of immunopotentiators].
    Wakida K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Mar; 39(3):432-8. PubMed ID: 3559328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oral administration of OK-432 (Picibanil) (7th report). Clinical application: effects on advanced and recurrent cancers].
    Nio Y; Ohgaki K; Kan N; Tsuchitani T; Imai S; Okino T; Hori T; Tobe T; Nakamura M; Kodama H
    Nihon Gan Chiryo Gakkai Shi; 1987 Dec; 22(10):2436-45. PubMed ID: 3449590
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies on the enhancement of anti-tumor activity in patients with cervical cancer by local administration of OK-432].
    Yamada Y; Yamamoto K; Wakita K; Shiraki S; Noda K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3427-31. PubMed ID: 3789753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of OK-432 on cytotoxic activity in cancer patients without tumor burden.
    Fujieda S; Saito H; Isobe Y; Nakagawara G; Nishi O; Nagahara K; Watanabe Y; Hoshino T
    Anticancer Res; 1992; 12(6B):1941-5. PubMed ID: 1341892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
    Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1607-15. PubMed ID: 2809385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of malignant ascites. II. Immunological studies on disappearance of ascites by intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
    Katano M
    Fukuoka Igaku Zasshi; 1981 Oct; 72(10):543-55. PubMed ID: 7327499
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical studies on the combined immunochemotherapy with a streptococcal preparation (Picibanil) and other anticancer drugs.
    Misawa S; Sawai K; Takino T; Masuda M; Abe T; Kawai K
    Nihon Gan Chiryo Gakkai Shi; 1979 Jun; 14(3):291-305. PubMed ID: 479655
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of biological response modifier on thoracic duct lymphocytes in recurrent gastric cancer. Evaluation of OK-432, a hemolytic streptococcus preparation.
    Hanaue H; Kim DY; Kubota M; Kurosawa T; Shikata J; Kondoh Y; Ogoshi K; Makuuchi H; Nakasaki H; Mitomi T
    Tokai J Exp Clin Med; 1987 May; 12(2):97-102. PubMed ID: 3502432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adoptive immunotherapy in tumor-bearing mice with OK-432-induced killer cells.
    Ujiie T
    Jpn J Exp Med; 1988 Apr; 58(2):109-14. PubMed ID: 3261814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432.
    Wakasugi H; Kasahara T; Minato N; Hamuro J; Miyata M; Morioka Y
    J Natl Cancer Inst; 1982 Oct; 69(4):807-12. PubMed ID: 6181282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Local immunotherapy with streptococcal preparation, OK-432 in superficial bladder tumors, and common antigens between OK-432 and the tumor].
    Fujioka T; Shiraishi M; Tanji S; Koike H; Suzuki K; Kumagai K; Aoki H; Sakuma Y; Ohhori T; Kubo T
    Hinyokika Kiyo; 1989 Feb; 35(2):253-7. PubMed ID: 2735236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental study of oral administration of streptococcal preparation "OK-432". The 6th report: its effect on in vivo anti-tumor immunity of the mice with transplanted cecal tumor].
    Tsuchitani T; Kodama H; Tobe T; Nio Y; Kan N; Inamoto T; Ohgaki K
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr; 20(3):609-17. PubMed ID: 2932509
    [No Abstract]   [Full Text] [Related]  

  • 34. [An experience of OK-432 intradermal administration in superficial bladder tumors].
    Tsujihashi H; Akiyama T; Kurita T; Iguchi M; Uejima S; Kataoka K; Minakata S; Kitagawa M; Sangen H
    Hinyokika Kiyo; 1988 Dec; 34(12):2111-4. PubMed ID: 3239522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of NK activity in regional lymph nodes by preoperative immunotherapy with OK-432 in patients with cancer of the oral cavity.
    Vinzenz K; Matejka M; Watzek G; Porteder H; Neuhold N; Micksche M
    Cancer Detect Prev Suppl; 1987; 1():463-75. PubMed ID: 3480060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Endoscopic administration of OK-432 in gastric cancer].
    Inbe A; Sumii K; Haruma K; Uemura N; Tari A; Yoshihara M; Tokutomi T; Inaba Y; Sekito M; Ogoshi H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):514-9. PubMed ID: 3954375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Administration of hemolytic streptococcus preparation OK-432 on recurrent gastric carcinoma].
    Hanaue H; Kurosawa T; Kitano Y; Miyagawa S; Nemoto A; Yamato H; Asagoe T; Shikata J
    Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1367-72. PubMed ID: 3501455
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunohistochemical studies on local antitumor effects of streptococcal immunopotentiator, OK-432, in human solid malignant tumors.
    Sugenoya A; Usuda N; Adachi W; Kaneko G; Nagata T; Iida F
    Arch Pathol Lab Med; 1988 May; 112(5):545-9. PubMed ID: 3282486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies of immunotherapy of malignant urogenital tumors: 2nd report. Changes in the K-cell population of the peripheral blood in patients with malignant tumors and the significance of antibody dependent cell-mediated cytotoxicity (ADCC) in OK-432 immunotherapy].
    Fujioka T; Tanji S; Koike H; Suzuki K; Aoki H; Banya Y; Kubo T; Ohhori T
    Nihon Hinyokika Gakkai Zasshi; 1987 Jan; 78(1):29-38. PubMed ID: 3599595
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of preoperative local administration of BRM on cellular immunity and prognosis of patients with esophageal cancer].
    Tanaka Y; Miyama T; Suda Y; Fujita K; Takubo K
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1780-3. PubMed ID: 1877817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.